基于CRISPR的精确分子诊断用于疾病检测和监测
Akshara Kulkarni1, Sadiya Tanga2, Arkadeep Karmakar3
1Ashoka University, Department of Biology, Rajiv Gandhi Education City, Sonipat, Haryana 131029, India.
ACS applied bio materials
|October 3, 2023
概括
克里斯普尔-卡斯技术为疾病监测和控制提供了灵敏,快速和便携的分子诊断. 本综述探讨了CRISPR-Cas系统在临床诊断方面的进展,提高了疾病检测能力.
科学领域:
- 分子生物学分子生物学
- 生物技术是生物技术.
- 医学诊断 医学诊断 医学诊断
背景情况:
- 随着COVID-19的爆发,人们更加需要先进的疾病监测和快速诊断工具.
- 克里斯普尔-卡斯系统已经成为基因操纵和特定序列基因编辑的强大工具.
- 克里斯珀-卡斯技术的发展为分子诊断开辟了新的途径.
研究的目的:
- 审查CRISPR-Cas系统在分子诊断中的进展和应用.
- 提供对基于CRISPR-Cas的诊断方法的全面了解.
- 突出CRISPR-Cas在临床诊断中的潜力.
主要方法:
- 关于CRISPR-Cas系统和分子诊断的科学文献的审查.
- 分析CRISPR-Cas在提高诊断测试灵敏度,准确性和可移植性方面的应用.
- 探索基于CRISPR-Cas的方法,用于临床应用.
主要成果:
- 克里斯普尔-卡斯技术显著提高了分子诊断的灵敏度,准确性和可移植性.
- 克里斯普尔-卡斯系统能够快速和精确地检测各种病原体.
- 这项技术对开发有效的临床诊断解决方案非常有前途.
结论:
- 克里斯普尔-卡斯系统代表了分子诊断的变革性技术.
- 这些系统对于未来的疾病监测,制和治疗至关重要.
- 进一步开发CRISPR-Cas诊断将增强全球卫生安全.
相关概念视频
CRISPR/Cas9 Genome Editing
39
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
39
CRISPR and crRNAs
17.1K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.1K


